You are here

  • Home
  • Archive
  • Volume 18, Issue 6
  • Varenicline and combination nicotine replacement therapy are the most effective pharmacotherapies for treating tobacco use

Article Text

Article menu
Download PDFPDF
Therapeutics
Systematic review and meta-analysis
Varenicline and combination nicotine replacement therapy are the most effective pharmacotherapies for treating tobacco use

https://doi.org/10.1136/eb-2013-101462

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests JOE has received research funding support from Pfizer, manufacturer of varenicline and consulting fees from GlaxoSmithKline, manufacturer of nicotine replacement products.

    Linked Articles